Morris L, Crocker P R, Hill M, Gordon S
Walter and Eliza Hall Institute, Melbourne, Australia.
Dev Immunol. 1992;2(1):7-17. doi: 10.1155/1992/74945.
Stromal macrophages in lymphohemopoietic tissues express novel macrophage-restricted plasma membrane receptors involved in nonphagocytic interactions with other hemopoietic cells. One such receptor with lectinlike specificity for sialylated glycoconjugates on sheep erythrocytes and murine hemopoietic cells has been characterized immunochemically and termed sialoadhesin. We have examined sialoadhesin expression during mouse development to learn more about its regulation and function. Immunocytochemical, rosetting, and Western blot studies show that sialoadhesin is first detected on fetal liver macrophages on day 18 of development, 7 days after numerous F4/80+ macrophages are found within erythroblastic islands. In spleen and bone marrow, sialoadhesin appears between day 18 and birth, in parallel with myeloid development. Strongly labeled macrophages in the marginal zone of spleen, characteristic of adult lymphoid tissues, appeared gradually between 1-4 weeks after birth, as the white pulp became enlarged. Isolation of fetal liver macrophages at day 14 confirmed that sialoadhesin was not involved in the binding of erythroblasts, which is mediated by a distinct cation-dependent receptor (Morris et al., 1988, p. 649). Sialoadhesin could be expressed by isolated fetal liver macrophages after cultivation in adult mouse serum, a known source of inducer activity, but was not dependent on the presence of this inducer, unlike adult-derived macrophages. Fetal plasma contained inducing activity on day 13, but adult levels were not reached until 2 weeks postnatally. These studies show that sialoadhesin is differentially regulated compared with the erythroblast receptor and F4/80 antigen, that it is not required for fetal erythropoiesis, and that its induction on stromal macrophages is delayed until the onset of myeloid and lymphoid development. Sialoadhesin provides a marker to study maturation and functions of macrophages during ontogeny of the lymphohemopoietic system.
淋巴造血组织中的基质巨噬细胞表达新型巨噬细胞限制性质膜受体,这些受体参与与其他造血细胞的非吞噬性相互作用。一种对绵羊红细胞和小鼠造血细胞上的唾液酸化糖缀合物具有凝集素样特异性的此类受体已通过免疫化学方法进行了表征,并被称为唾液酸黏附素。我们研究了小鼠发育过程中唾液酸黏附素的表达,以更多地了解其调控和功能。免疫细胞化学、玫瑰花结形成和蛋白质印迹研究表明,在发育的第18天,在胎儿肝脏巨噬细胞上首次检测到唾液酸黏附素,此时距离在成红细胞岛中发现大量F4/80 +巨噬细胞已有7天。在脾脏和骨髓中,唾液酸黏附素在第18天至出生之间出现,与髓系发育同步。出生后1 - 4周,随着白髓扩大,脾脏边缘区出现强烈标记的巨噬细胞,这是成年淋巴组织的特征。在第14天分离胎儿肝脏巨噬细胞证实,唾液酸黏附素不参与成红细胞的结合,成红细胞的结合是由一种独特的阳离子依赖性受体介导的(莫里斯等人,1988年,第649页)。在成年小鼠血清(一种已知的诱导活性来源)中培养后,分离的胎儿肝脏巨噬细胞可以表达唾液酸黏附素,但与成年来源的巨噬细胞不同,它不依赖于这种诱导剂的存在。胎儿血浆在第13天含有诱导活性,但直到出生后2周才达到成年水平。这些研究表明,与成红细胞受体和F4/80抗原相比,唾液酸黏附素受到不同的调控,胎儿红细胞生成不需要它,并且其在基质巨噬细胞上的诱导延迟到髓系和淋巴系发育开始。唾液酸黏附素为研究淋巴造血系统个体发育过程中巨噬细胞的成熟和功能提供了一个标志物。